16 of 110 unique stocks in common · Jaccard: 14.5%
A weighted portfolio overlap of 11.11% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹11.11 is allocated to the exact same companies at the same relative proportions. The schemes share 16 common holdings.
The largest overlapping asset in their portfolios is Sun Pharmaceutical Industries, which commands a weight of 2.65% in ICICI Prudential Large Cap Fund and 2.97% in SBI MNC Fund. Holding both schemes increases your concentration in Sun Pharmaceutical Industries rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in SBI |
|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | 2.65% | 2.97% |
| Maruti Suzuki IndiaAutomobiles | 3.55% | 2.17% |
| Hyundai Motor IndiaAutomobiles | 0.95% | 2.22% |
| Britannia IndustriesFood Products | 0.91% | 2.58% |
| Cummins IndiaIndustrial Products | 0.91% | 5.82% |
| Hindustan UnileverDiversified FMCG | 0.83% | 2.49% |
| SiemensElectrical Equipment | 0.77% | 3.17% |
| ABB IndiaElectrical Equipment | 0.36% | 2.99% |
| CiplaPharmaceuticals & Biotechnology | 0.33% | 1.62% |
| VedantaDiversified Metals | 0.29% | 3.26% |
| United BreweriesBeverages | 0.30% | 0.22% |
| LupinPharmaceuticals & Biotechnology | 0.19% | 0.75% |
| Malco EnergyOil | 0.13% | 1.12% |
| Talwandi Sabo PowerPower | 0.13% | 1.12% |
| Vedanta Aluminium MetalNon - Ferrous Metals | 0.13% | 1.12% |
| Vedanta Iron And SteelFerrous Metals | 0.13% | 1.12% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.